Adakveo (crizanlizumab-tmca)

Adult Dosing .

Dosage forms:  INJ

Special Note

[formulation clarification]

Info: nonproprietary name = crizanlizumab-tmca

sickle cell dz

[5 mg/kg/dose IV q4wk starting wk 6]

Start: 5 mg/kg/dose IV q2wk on wk 0, 2; Info: use w/ or w/o hydroxyurea

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  INJ

Special Note

[formulation clarification]

Info: nonproprietary name = crizanlizumab-tmca

sickle cell dz

[16 yo and older]

Dose: 5 mg/kg/dose IV q4wk starting wk 6; Start: 5 mg/kg/dose IV q2wk on wk 0, 2; Info: use w/ or w/o hydroxyurea

renal dosing

[not defined]

renal impairment: not defined

HD/PD: not defined

hepatic dosing

[not defined]